Ilaris ratings & reviews

Canakinumab
Company: Novartis
Brand: Ilaris
Drug class: Musculo-Skeletal System
+6 more
Musculo-Skeletal System, Antineoplastic and Immunomodulating Agents, Agents that Suppress the Immune System, Antiinflammatory Agents and Antirheumatic Agents, Interleukin-1 Beta (IL-1 Beta) Inhibitors, Specific Anti-Rheumatic Agents, Anti-Rheumatic Monoclonal Antibodies

Great minds are at work! Once enough Sermo physicians weigh in, the rating will be displayed here

empty star empty star empty star empty star empty star

Sermo AI Overview

  • Ilaris is generally recognized for its efficacy in treating systemic juvenile idiopathic arthritis, while opinions among physicians on its effectiveness for Still's disease vary, with an average rating of 3.7 out of 5, reflecting mixed patient experiences.
  • Challenges with accessibility and adherence have been noted, particularly in rural areas where obtaining the medication can be difficult. This concern is compounded by the drug's high cost, which limits access for patients across multiple conditions.
  • Some patients struggle with adherence to Ilaris due to the need for frequent injections and the medication's overall expense. These factors can significantly impact treatment outcomes, especially for those with rarer diseases like cryopyrin-associated periodic syndromes.
  • Was this summary helpful?
Based on insights from Sermo’s triple verified physicians

Description

Ilaris contains the active ingredient canakinumab. It is a monoclonal antibody. The drug is designed to decrease inflammation.

Source: This information is sourced from FDA and powered by AI

Dosage & Administration

How should I use this medication?

This medication is injected under the skin. It is given by a care team in a hospital or clinic setting.

A special MedGuide will be given to you before each treatment. Be sure to read this information carefully each time.

Talk to your care team about the use of this medication in children. While this medication may be prescribed for children as young as 2 years for selected conditions, precautions do apply.

Overdosage: If you think you have taken too much of this medicine contact a poison control center or emergency room at once.

NOTE: This medicine is only for you. Do not share this medicine with others.

What if I miss a dose?

Keep appointments for follow-up doses. It is important not to miss your dose. Call your care team if you are unable to keep an appointment.

Where should I keep my medication?

This medication is given in a hospital or clinic. It will not be stored at home.

NOTE: This sheet is a summary. It may not cover all possible information. If you have questions about this medicine, talk to your doctor, pharmacist, or health care provider.

Side Effects

What side effects may I notice from receiving this medication?

Side effects that you should report to your care team as soon as possible:

  • Allergic reactions—skin rash, itching, hives, swelling of the face, lips, tongue, or throat
  • Infection—fever, chills, cough, sore throat, wounds that don't heal, pain or trouble when passing urine, general feeling of discomfort or being unwell
  • Rash, fever, and swollen lymph nodes

Side effects that usually do not require medical attention (report these to your care team if they continue or are bothersome):

  • Back pain
  • Diarrhea
  • Headache
  • Nausea
  • Runny or stuffy nose
  • Sore throat
  • Weight gain

This list may not describe all possible side effects. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Warnings & Precautions

What should I tell my care team before I take this medication?

They need to know if you have any of these conditions:

  • Cancer
  • Hepatitis
  • HIV or AIDS
  • Immune system problems
  • Infection, such as tuberculosis (TB) or other bacterial, fungal, or viral infections
  • Low blood cell levels (white cells, red cells, and platelets)
  • Recent or upcoming vaccine
  • An unusual or allergic reaction to canakinumab, other medications, foods, dyes, or preservatives
  • Pregnant or trying to get pregnant
  • Breast-feeding

What may interact with this medication?

Do not take this medication with any of the following:

  • Biologic medications, such as adalimumab, anakinra, certolizumab, etanercept, golimumab, infliximab
  • Live virus vaccines

This medication may also interact with the following:

  • Abatacept
  • Baricitinib
  • Medications that lower your chance of fighting an infection
  • Rilonacept
  • Rituximab
  • Sarilumab
  • Tocilizumab
  • Tofactinib
  • Upadacitinib
  • Warfarin

This list may not describe all possible interactions. Give your health care provider a list of all the medicines, herbs, non-prescription drugs, or dietary supplements you use. Also tell them if you smoke, drink alcohol, or use illegal drugs. Some items may interact with your medicine.

What should I watch for while using this medication?

Your condition will be monitored carefully while you are receiving this medication. Tell your care team if your symptoms do not start to get better or if they get worse. You may need blood work while taking this medication.

You will be tested for tuberculosis (TB) before you start this medication. If your care team prescribed any medication for TB, you should start taking the TB medication before starting this medication. Make sure to finish the full course of TB medication.

This medication may increase your risk of getting an infection. Call your care team for advice if you get a fever, chills, sore throat, or other symptoms of a cold or flu. Do not treat yourself. Try to avoid being around people who are sick.

Source: This information is sourced from Elsevier Inc.

Disclaimer

The reviews, ratings, comments, and opinions expressed on this platform are solely those of the individual medical professionals who posted them and do not reflect the views or positions of Sermo, Inc. Sermo does not endorse, verify, or validate the content of individual reviews. The information provided is user-generated and reflects personal clinical experiences, which may not be complete, accurate, or applicable to your specific health needs. It is not intended as medical advice.

Prescription medications affect individuals differently, and what works for one person may not work for another. Always consult your doctor, pharmacist, or other qualified healthcare provider to ensure the information displayed applies to your personal circumstances. Only a licensed healthcare provider can advise you on what is safe and effective for you.

Keep all medications out of the reach of children, never share your medicine with others, and use each medication only as prescribed. Your reliance on any information provided on this platform is at your own risk.

Terms of use

  1. Sermo Drug Ratings, and all information provided on this website, may not be used in combination with any artificial intelligence tool (including to train an algorithm, test, process, analyze, generate output and/or develop any form of artificial intelligence tool). 

  2. Visitors to the online patient-facing website at Sermo.com (“Sermo Drug Ratings”) are Authorized Users of the website, which contains data owned by a third-party provider, Elsevier, Inc.  Accordingly, by visiting Sermo Drug Ratings, Authorized User acknowledges that the website includes Elsevier owned data that Sermo licenses pursuant to a separate usage and Data agreement (the “Agreements”).  Authorized User further acknowledges that Sermo is a third-party beneficiary of the Agreements and Authorized User’s use of the website hereby binds them to the terms of the Agreements; provided, however, that Elsevier shall have no obligations or liability to an Authorized User whatsoever pursuant to the terms of the Agreements.

  3. Authorized User acknowledges and agrees that the Elsevier Products are designed for and are intended to be used by those residing in the United States, and that the information contained in the Elsevier Products does not comply with any laws or practices outside of the United States. You assume all responsibilities, duties, and obligations for any treatment, decision, or advice made or given to third parties as a result of the use or application of the Elsevier Products outside of the United States, and Sermo, Elsevier and its affiliates, subsidiaries, agents and suppliers will incur no liability for any use or application of the Products by Authorized Users outside of the United States.

Welcome to Sermo's Drug Ratings

Previously only for members, Sermo Drug Ratings are now openly available to all healthcare providers, patients, and industry professionals to support better healthcare decisions.

Clinical expertise
Insights based on real prescribing experience from triple-verified practicing physicians only
Detailed insights
Ratings on key attributes including efficacy, safety, tolerability, accessibility, and adherence
Unbiased reviews
Independent, physician-only reviews, free from pharmaceutical industry influence